Similarly, during cardiac events, PIEZO1, when activated by physiological mechanical stress, often plays a role in maintaining cardiac pumping function and anti-fibrotic effects; however, when abnormally activated by pathological factors, PIEZO1 begins to promote pathological cardiac hypertrophy, cardiac fibrosis, and even heart failure. This evidence concerns the gene PIEZO1 and cardiac hypertrophy.